A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design (Q24647087)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design	scientific article

Statements

scholarly article

0 references

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design (English)

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

6

object named as

Jean-Lucien Rouleau

0 references

Guillermo Torre-Amione

1

object named as

Guillermo Torre-Amione

0 references

Wilson S Colucci

3

object named as

Wilson S Colucci

0 references

author name string

Robert C Bourge

2

0 references

Barry Greenberg

4

0 references

Craig Pratt

5

0 references

Francois Sestier

7

0 references

Lemuel A Moyé

8

0 references

John A Geddes

9

0 references

Agnes J Nemet

10

0 references

James B Young

11

0 references

language of work or name

0 references

publication date

April 2007

0 references

The Canadian Journal of Cardiology

0 references

23

0 references

5

0 references

369-76

0 references

Effects of VasoCare therapy on the initiation and progression of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

7 April 2017

Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

7 April 2017

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

7 April 2017

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

27 September 2017

Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

27 September 2017

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

27 September 2017

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

27 September 2017

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

30 May 2018

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

30 May 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

28 November 2018

Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

28 November 2018

A randomised, double blind, placebo-controlled study to determine the efficacy of immune modulation therapy in the treatment of patients suffering from peripheral arterial occlusive disease with intermittent claudication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2649187

28 November 2018

The effect of VAS972 on allergic contact hypersensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive effects of apoptotic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor Necrosis Factor-α Is Persistently Expressed in Cardiac Allografts in the Absence of Histological or Clinical Evidence of Rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

https://pubmed.ncbi.nlm.nih.gov/17440642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0828-282X(07)70770-5

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24647087&oldid=2116365651"